EUDA Health Holdings Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EUDA research report →
Price Chart
About the company
EUDA Health Limited, established in 2019, is a Singapore-based enterprise dedicated to advancing digital healthcare. It provides an innovative platform facilitating online medical consultations for routine, non-urgent health concerns. This entity functions as a subsidiary of Watermark Developments Limited.
- CEO
- Alfred Lim
- IPO
- 2021
- Employees
- 123
- HQ
- Singapore, CE, SG
Get TickerSpark's AI analysis on EUDA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $26.52M
- P/E
- -5.55
- Fwd P/E
- 8.87
- PEG
- 0.06
- P/S
- 2.26
- P/B
- -6.20
- EV/EBITDA
- -7.66
- Div Yield
- 0.00%
- Gross Margin
- 41.73%
- Op Margin
- -36.42%
- Net Margin
- -40.49%
- ROE
- 119.56%
- ROIC
- 239.94%
Latest fiscal year · YoY change
- Revenue
- $6.82M+70.0%
- Gross Profit
- $2.99M+292.7%
- Op Income
- $-2,440,512
- Net Income
- $-2,772,762+81.9%
- EPS
- $-1.49+84.1%
- OCF Growth
- -19.3%
- FCF Growth
- -17.7%
- 52W High
- $86.00
- 52W Low
- $5.26
- 50D MA
- $14.82
- 200D MA
- $24.60
- Beta
- 0.64
- RSI (14)
- 45
- Avg Volume
- 4.78K
No earnings-call transcripts are available for EUDA yet.
- Free Float
- 50.4%
- Shares Outstanding
- 1.87M
- Float Shares
- 941.21K
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 18, 26 | Tay Whye Shin | other | 0 |
| Mar 18, 26 | Liew Kwong Yeow | other | 0 |
| Mar 18, 26 | Lew Chern Yong | other | 0 |
| Mar 18, 26 | Huang Bo | other | 0 |
| Jun 12, 23 | Chen Wei Wen Kelvin | other | 271,867 |
| May 22, 23 | Wong KongYew | other | 0 |
| May 16, 23 | Chen Wei Wen Kelvin | other | 850,306 |
| May 22, 23 | Rajpal Ajay | other | 0 |
| Nov 24, 21 | Tan Meng Dong (James) | buy | 292,250 |
| Nov 24, 21 | Tan Meng Dong (James) | buy | 292,250 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our EUDA coverage
Recent articles, reports, and earnings notes.
No research on EUDA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate EUDA report →EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products
globenewswire.com · Jul 30
EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products
globenewswire.com · Jul 30
EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Therapies
globenewswire.com · Jul 28
EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Therapies
globenewswire.com · Jul 28
Phreesia (NYSE:PHR) & EUDA Health (NASDAQ:EUDA) Head-To-Head Review
defenseworld.net · Jul 28
EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask
globenewswire.com · Jun 1
EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask
globenewswire.com · Jun 1
EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency
globenewswire.com · Jun 1
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.